Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/00 → 1/1/00 |
A Phase 1/2a Open-Label Dose-Ranging and Observer-Blind Placebo-Controlled, Safety and Immunogenicity Study of mRNA-1647 Cytomegalovirus Vaccine in Female and Male Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age
- Rupp, Richard (PI)
Project: Other project